跳至主要内容
临床试验/JPRN-UMIN000026260
JPRN-UMIN000026260招募中未知

Prospective cohort study on patients of pancreatic cancer performed EUSFNA - Prospective cohort study on patients of pancreatic cancer performed EUSFNA

Division of Gastroenterology, Department of Internal medicine, Kobe University Graduate School of Medicine0 个研究点目标入组 1,000 人开始时间: 2017年2月22日最近更新:
适应症

试验速览

阶段
未知
状态
招募中
发起方
入组人数
1,000

研究概览

简要总结

The aim of this research is registry of pancreatic cancer performed EUSFNA. Therefore there is no main outcome. In each individual study, we will perform UMIN registration.

研究设计

研究类型
Observational

入排标准

年龄范围
20years-old 至 100years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • 未提供

研究者

发起方
Division of Gastroenterology, Department of Internal medicine, Kobe University Graduate School of Medicine

相似试验

进行中(未招募)
不适用
Cohort Study of Pancreatic Cancer RiskFamilial Pancreatic Cancer
NCT04247503Mayo Clinic419
已完成
不适用
Observational study of pancreatic cancer patients with positive peritoneal lavage cytologypancreatic cancer
JPRN-UMIN000032477Shizuoka Cancer Center150
进行中(未招募)
不适用
A trial comparing the current standard treatment (gemcitabine) to the experimental, combined treatments of gemcitabine plus capecitabine.Resectable pancreatic or peri-ampullary cancersMedDRA version: 14.1Level: LLTClassification code 10033602Term: Pancreatic adenocarcinoma resectableSystem Organ Class: 100000004864MedDRA version: 14.1Level: LLTClassification code 10034446Term: Periampullary carcinoma resectableSystem Organ Class: 100000004864
EUCTR2007-004299-38-GBThe University of Liverpool1,396
进行中(未招募)
1 期
Comparing Gemcetabine and Capecitabine versus Gemcitabine monotherapy in chemotherapy for pancreatic cancerResectable pancreatic cancerMedDRA version: 21.0Level: LLTClassification code 10033602Term: Pancreatic adenocarcinoma resectableSystem Organ Class: 100000004864
EUCTR2007-004299-38-DEThe University of Liverpool1,068
进行中(未招募)
1 期
European Study Group for Pancreatic Cancer - Trial 4. Combination versus single agent adjuvant chemotherapy in resectable pancreatic cancer. - ESPAC-4Resectable pancreatic cancerMedDRA version: 14.1Level: LLTClassification code 10033602Term: Pancreatic adenocarcinoma resectableSystem Organ Class: 100000004864
EUCTR2007-004299-38-SEThe University of Liverpool1,080
Prospective cohort study on patients of pancreatic... | 临床试验